Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (CTRI/2026/10/119254) titled 'A study comparing Infliximab versus methylprednisolone in children with Kawasaki Disease' on Oct. 9.
Study Type: Interventional
Study Design:
Randomized, Parallel Group Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Open Label
Primary Sponsor: Dr Shrutirupa Bandyopadhyay
Condition:
Health Condition 1: M303- Mucocutaneous lymph node syndrome[Kawasaki]
Intervention:
Intervention1: Infliximab: Infliximab 10 mg per kg administered over 2 hours as intensification of th...